Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / CL B
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
109,107
-
Shares change
-
-1,194
-
Total reported value, excl. options
-
$82,364,000
-
Value change
-
-$898,882
-
Number of buys
-
2
-
Number of sells
-
-2
-
Price
-
$755.18
Significant Holders of BIO RAD LABS INC - CL B (BIOB) as of Q4 2021
12 filings reported holding BIOB - BIO RAD LABS INC - CL B as of Q4 2021.
BIO RAD LABS INC - CL B (BIOB) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 109,107 shares
.
Largest 10 shareholders include Tikvah Management LLC (97,027 shares), CSS LLC/IL (7,375 shares), RENAISSANCE TECHNOLOGIES LLC (2,200 shares), MORGAN STANLEY (692 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (496 shares), GAMCO INVESTORS, INC. ET AL (310 shares), UBS Group AG (299 shares), OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC (284 shares), Gemmer Asset Management LLC (279 shares), and WELLS FARGO & COMPANY/MN (56 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.